Literature DB >> 25352593

δ-Conotoxins synthesized using an acid-cleavable solubility tag approach reveal key structural determinants for NaV subtype selectivity.

Steve Peigneur1, Marianne Paolini-Bertrand2, Hubert Gaertner2, Daniel Biass3, Aude Violette3, Reto Stöcklin3, Philippe Favreau4, Jan Tytgat5, Oliver Hartley6.   

Abstract

Conotoxins are venom peptides from cone snails with multiple disulfide bridges that provide a rigid structural scaffold. Typically acting on ion channels implicated in neurotransmission, conotoxins are of interest both as tools for pharmacological studies and as potential new medicines. δ-Conotoxins act by inhibiting inactivation of voltage-gated sodium channels (Nav). Their pharmacology has not been extensively studied because their highly hydrophobic character makes them difficult targets for chemical synthesis. Here we adopted an acid-cleavable solubility tag strategy that facilitated synthesis, purification, and directed disulfide bridge formation. Using this approach we readily produced three native δ-conotoxins from Conus consors plus two rationally designed hybrid peptides. We observed striking differences in Nav subtype selectivity across this group of compounds, which differ in primary structure at only three positions: 12, 23, and 25. Our results provide new insights into the structure-activity relationships underlying the Nav subtype selectivity of δ-conotoxins. Use of the acid-cleavable solubility tag strategy should facilitate synthesis of other hydrophobic peptides with complex disulfide bridge patterns.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Conotoxin; Molecular Pharmacology; Natural Product Biosynthesis; Neurotoxin; Peptide Chemical Synthesis; Sodium Channel

Mesh:

Substances:

Year:  2014        PMID: 25352593      PMCID: PMC4271220          DOI: 10.1074/jbc.M114.610436

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  NMR solution structures of delta-conotoxin EVIA from Conus ermineus that selectively acts on vertebrate neuronal Na+ channels.

Authors:  Laurent Volpon; Hung Lamthanh; Julien Barbier; Nicolas Gilles; Jordi Molgó; André Ménez; Jean-Marc Lancelin
Journal:  J Biol Chem       Date:  2004-02-19       Impact factor: 5.157

Review 2.  Conus venom peptide pharmacology.

Authors:  Richard J Lewis; Sébastien Dutertre; Irina Vetter; MacDonald J Christie
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 3.  Mining invertebrate natural products for future therapeutic treasure.

Authors:  Youmie Park
Journal:  Nat Prod Commun       Date:  2011-09       Impact factor: 0.986

4.  Comparative proteomic study of the venom of the piscivorous cone snail Conus consors.

Authors:  Daniel Biass; Sébastien Dutertre; Alain Gerbault; Jean-Louis Menou; Robin Offord; Philippe Favreau; Reto Stöcklin
Journal:  J Proteomics       Date:  2009-01-23       Impact factor: 4.044

5.  Use of a temporary "solubilizing" peptide tag for the Fmoc solid-phase synthesis of human insulin glargine via use of regioselective disulfide bond formation.

Authors:  Mohammed Akhter Hossain; Alessia Belgi; Feng Lin; Suode Zhang; Fazel Shabanpoor; Linda Chan; Chris Belyea; Hue-Trung Truong; Amy R Blair; Sof Andrikopoulos; Geoffrey W Tregear; John D Wade
Journal:  Bioconjug Chem       Date:  2009-07       Impact factor: 4.774

Review 6.  Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.

Authors:  Massimo Mantegazza; Giulia Curia; Giuseppe Biagini; David S Ragsdale; Massimo Avoli
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

7.  Purification, characterization, synthesis, and cloning of the lockjaw peptide from Conus purpurascens venom.

Authors:  K J Shon; M M Grilley; M Marsh; D Yoshikami; A R Hall; B Kurz; W R Gray; J S Imperial; D R Hillyard; B M Olivera
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

8.  Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product.

Authors:  S J Bogdanowich-Knipp; S D Jois; T J Siahaan
Journal:  J Pept Res       Date:  1999-07

9.  A delta-conotoxin from Conus ermineus venom inhibits inactivation in vertebrate neuronal Na+ channels but not in skeletal and cardiac muscles.

Authors:  Julien Barbier; Hung Lamthanh; Frédéric Le Gall; Philippe Favreau; Evelyne Benoit; Haijun Chen; Nicolas Gilles; Nitza Ilan; Stefan H Heinemann; Dalia Gordon; André Ménez; Jordi Molgó
Journal:  J Biol Chem       Date:  2003-11-13       Impact factor: 5.157

10.  Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Front Pharmacol       Date:  2011-10-04       Impact factor: 5.810

View more
  4 in total

1.  A Helping Hand to Overcome Solubility Challenges in Chemical Protein Synthesis.

Authors:  Michael T Jacobsen; Mark E Petersen; Xiang Ye; Mathieu Galibert; George H Lorimer; Vincent Aucagne; Michael S Kay
Journal:  J Am Chem Soc       Date:  2016-09-01       Impact factor: 15.419

2.  Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities.

Authors:  Pascal Heimer; Thomas Schmitz; Charlotte A Bäuml; Diana Imhof
Journal:  J Vis Exp       Date:  2018-10-02       Impact factor: 1.355

3.  Small cyclic sodium channel inhibitors.

Authors:  Steve Peigneur; Cristina da Costa Oliveira; Flávia Cristina de Sousa Fonseca; Kirsten L McMahon; Alexander Mueller; Olivier Cheneval; Ana Cristina Nogueira Freitas; Hana Starobova; Igor Dimitri Gama Duarte; David J Craik; Irina Vetter; Maria Elena de Lima; Christina I Schroeder; Jan Tytgat
Journal:  Biochem Pharmacol       Date:  2020-10-17       Impact factor: 6.100

4.  Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel.

Authors:  A C Baumruck; D Tietze; L K Steinacker; A A Tietze
Journal:  Chem Sci       Date:  2018-01-22       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.